HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US International Mail Shipment Searches Reap More Spiked Supplements

Executive Summary

Between start of federal government partial shutdown on Dec. 22 and federal agencies' re-opening on Jan. 28, FDA Customs and Border Protection officials examining international mail shipments found ED drugs in six products and two weight loss ingredients approved in the US in four.

You may also be interested in...

Nearly 50,000 Claire's Packages Recalled; More ED Drugs In Supplements

Three makeup products tainted with asbestos Claire Stores recalled after initially refusing FDA's request, and second and third recalls of tattoo ink in 2019 are among health, beauty and wellness product recalls listed in agency's latest updates. FDA also ED drug sildenafil in another product marketed as a dietary supplement.

FDA Consumer Health Market Oversight Stays In Spotlight In Gottlieb's Final Week

In four days before Scott Gottlieb's stint as commissioner ended, FDA announced official start of initiative to consider regulatory pathways to make CBD compliant as a dietary ingredient, launched another shot across kratom sector's bow and noted more examples of e-cigarette marketers crossing regulatory lines.

CVS, Wal-Mart Store Brand Infant Ibuprofen Recalled

Tris Pharma is recalling OTC infants’ ibuprofen concentrated oral suspension products it made of Wal-Mart, CVS and Family Dollar store brands. Two firms have recalled antiseptic washes, Ecolab due to a labeling error and Avkare due to microbial contamination.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts